Evidence map›Paper›PMID 21094031›Full record

ReviewCurrent opinion in immunology2011

Regulation of innate immunity by signaling pathways emerging from the endoplasmic reticulum.

Fabio Martinon, Laurie H Glimcher

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 142 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Endoplasmic reticulum's role in multiple sclerosis, exploring potential biomarkers, and pioneering therapeutic strategies: a comprehensive review of literature.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Fabio MartinonDepartment of Biochemistry, University of Lausanne, 155 Ch. Des Boveresses, Epalinges 1066, Switzerland.
Laurie H Glimcher
Harvard University · USUniversity of Lausanne · CH

Funding

Arming the Immune System Against PathogensP01AI056296 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI GLIMCHER, LAURIE HOLLIS · 2003 to 2007
$20.0M
TRANSCRIPTIONAL REGULATION OF THE IMMUNE RESPONSER01AI032412 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI GLIMCHER, LAURIE HOLLIS · 1991 to 2010
$4.6M
NIAID NIH HHS AI32412NIAID NIH HHS AI56296NIAID NIH HHS P01 AI056296NIAID NIH HHS R01 AI032412
6 · The paper itself

Abstract

The innate immune system has evolved the capacity to detect specific pathogens and to interrogate cell and tissue integrity in order to mount an appropriate immune response. Loss of homeostasis in the endoplasmic reticulum (ER) triggers the ER-stress response, a hallmark of many inflammatory and infectious diseases. The IRE1/XBP1 branch of the ER-stress signaling pathway has been recently shown to regulate and be regulated by innate immune signaling pathways in both the presence and absence of ER-stress. By contrast, innate immune pathways negatively affect the activation of two other branches of the ER-stress response as evidenced by reduced expression of the pro-apoptotic transcription factor CHOP. Here we will discuss how innate immune pathways and ER-signaling intersect to regulate the intensity and duration of innate immune responses.

Indexed as

Immunity, InnateSignal TransductionAnimalsEndoplasmic ReticulumHumansProtein UnfoldingReceptors, ImmunologicStress, PhysiologicalReceptors, Immunologic

Identifiers

PMID21094031
PMCPMC3042531
OpenAlexW2005423664

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.